Athens Medical C.S.A. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	270.92	269.85	258.36	233.42	226	187.5
Revenue Growth (YoY)	1.56%	4.44%	10.69%	3.28%	20.53%	-4.95%
Cost of Revenue	216.92	209.08	191.81	176.61	168.21	146.78
Gross Profit	54	60.76	66.56	56.81	57.79	40.72
Selling, General & Admin	50.67	48.73	45.5	40.63	37.26	32.5
Other Operating Expenses	-3.17	-3.12	-2	-2.39	-2.91	-0.66
Operating Expenses	47.7	45.81	43.68	38.54	35.05	32.92
Operating Income	6.3	14.96	22.87	18.28	22.73	7.8
Interest Expense	-10.14	-10.7	-9.33	-7.64	-6.55	-6.14
Interest & Investment Income	0.31	0.32	0.33	0.12	0.2	2.1
Other Non Operating Income (Expenses)	0.34	-0.13	-0.13	-0.13	-0.13	-0.19
EBT Excluding Unusual Items	-3.19	4.45	13.75	10.64	16.26	3.57
Gain (Loss) on Sale of Investments	0.02	-	-	-	-	-
Gain (Loss) on Sale of Assets	0.05	0.05	-0.05	0.08	-1.37	0.05
Other Unusual Items	-	-	-	-	0.45	-
Pretax Income	-3.12	4.5	13.7	10.71	15.34	3.62
Income Tax Expense	1.53	2.61	5.54	3.8	3.3	1.19
Earnings From Continuing Operations	-4.64	1.89	8.16	6.92	12.04	2.43
Earnings From Discontinued Operations	-	-	-	-	3.1	1.54
Net Income to Company	-4.64	1.89	8.16	6.92	15.14	3.97
Minority Interest in Earnings	-0.09	-0.11	-0.08	-0.07	-0.09	-0.05
Net Income	-4.73	1.78	8.08	6.85	15.05	3.92
Net Income to Common	-4.73	1.78	8.08	6.85	15.05	3.92
Net Income Growth	-	-77.99%	18.05%	-54.51%	283.54%	-48.29%
Shares Outstanding (Basic)	87	87	87	87	87	87
Shares Outstanding (Diluted)	87	87	87	87	87	87
EPS (Basic)	-0.05	0.02	0.09	0.08	0.17	0.05
EPS (Diluted)	-0.05	0.02	0.09	0.08	0.17	0.05
EPS Growth	-	-77.99%	18.05%	-54.51%	283.54%	-48.29%
Free Cash Flow	-5.71	19.82	3.78	-15.75	4.47	33.13
Free Cash Flow Per Share	-0.07	0.23	0.04	-0.18	0.05	0.38
Dividend Per Share	-	-	0.020	-	0.070	-
Gross Margin	19.93%	22.52%	25.76%	24.34%	25.57%	21.72%
Operating Margin	2.33%	5.54%	8.85%	7.83%	10.06%	4.16%
Profit Margin	-1.75%	0.66%	3.13%	2.93%	6.66%	2.09%
Free Cash Flow Margin	-2.11%	7.34%	1.46%	-6.75%	1.98%	17.67%
EBITDA	17.55	25.78	32.85	27.64	31.48	16.29
EBITDA Margin	6.48%	9.55%	12.71%	11.84%	13.93%	8.69%
D&A For EBITDA	11.25	10.83	9.98	9.36	8.75	8.49
EBIT	6.3	14.96	22.87	18.28	22.73	7.8
EBIT Margin	2.33%	5.54%	8.85%	7.83%	10.06%	4.16%
Effective Tax Rate	-	58.06%	40.44%	35.44%	21.51%	32.79%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.